Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
At Max Super Speciality Hospital, Saket, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2006, the JCI, NABH accredited hospital is located in Delhi, India, and has 539 beds.
Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.
Gurgaon, India
The state-of-the-art Targeted Therapy services offered by Fortis Memorial Research Institute, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Gurgaon, India. Founded in 2013, the JCI, NABH, NABL accredited hospital has 311 beds and provides cancer care facilities for all its local and overseas patients.
Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.
With advanced oncology infrastructure, Asian Institute of Medical Sciences offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2010, the NABL, NABH accredited hospital is located in Faridabad, India, and has 425 beds.
Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.
With advanced oncology infrastructure, Manipal Hospitals Goa, Dona Paula offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 1994, the NABH accredited hospital is located in Panjim, India, and has 235 beds.
Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.
Sanar International Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, JCI, AACI accredited hospital was established in 2018 in Gurugram, India and has 150 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
VPS Lakeshore Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, ISO accredited hospital was established in 2003 in Kochi, India and has 350 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
With advanced oncology infrastructure, Apollo Multispecialty Hospitals offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2003, the JCI, ISO accredited hospital is located in Kolkata, India, and has 700 beds.
Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.
Apollo Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 1983 in Chennai, India and has 550 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
Fortis Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, NABL accredited hospital was established in 2004 in Noida, India and has 400 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
At Manipal Hospital, Dwarka, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The NABH accredited facility has been functioning since 2018 and is located in Delhi, India. The hospital has 380 beds and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.
With advanced oncology infrastructure, Fortis Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2001, the NABH, NABL, JCI accredited hospital is located in Bangalore, India, and has 375 beds.
Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.
Faridabad, India
At Sarvodaya Hospital and Research Centre, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The NABH, NABL accredited facility has been functioning since 1997 and is located in Faridabad, India. The hospital has 500 beds and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.
OncoCare Cancer Centre aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH accredited hospital was established in 2020 in Amroha, India and it has adequate bed capacity to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
Batra Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH accredited hospital was established in 1987 in Delhi, India and has 495 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
Fortis Hiranandani Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH accredited hospital was established in 2007 in Mumbai, India and has 149 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing episodes of unconsciousness. After a…
Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for Ovarian Cancer Treatment in Turkey.
| Speciality | Oncology |
| Procedure | Targeted Therapy |
| Success Rate | Varies as per stage, grade and type of cancer |
| Recovery Time | Few weeks to several months |
| Treatment Time | A few months to a year |
| Chances of Recurrence | Varies as per stage, grade, type and location of cancer |
All the latest medical technology is available in India's targeted therapy hospitals. Most top-rated hospitals and healthcare facilities invest in precision medicine, advanced treatment methods, and high-end diagnostic tools to give patients the best results after receiving the targeted therapy.
The top hospitals that provide Targeted Therapy in India have the following features:
The success rate of targeted therapy is about 80%, while in the case of chemotherapy, the success rate of chemotherapy is 30%.
You can explore the list of trustworthy, accredited hospitals in India that provide Targeted Therapy on the MediGence platform. It also shows the profiles of oncologists by their experience, success rates, and reviews to help you find the best ones to connect with. This results in a seamless and informed journey to find the most personalised medical solutions for cancer treatment.
Few hospitals in India offer Targeted Therapy:
The cost of Targeted Therapy in India typically ranges from (USD 8000 - 12000), depending on the hospital, location, and the complexity of the procedure.
Many hospitals in India offering Targeted Therapy specialise in treating international patients. They arrange travel and accommodation and plan treatment. Even Top-Notch Hospitals like Artemis, Fortis, and Medanta provide excellent treatment and care for their global patients.
There are some risks associated with Targeted Therapy, such as:
Recovery in India following targeted therapy depends on the patient's health, type of cancer, and kind of therapy. Most recover within weeks to months. Modest side effects, such as fatigue and skin sensitivity, are noted.
You can consult with an oncologist before travelling to India for Targeted Therapy through the MediGence platform. MediGence offers tele consultations with top oncologists, allowing you to discuss your medical condition, treatment options, and expert advice.
In India, post-operative care after targeted therapy is usually monitored closely for any adverse effects, such as minor nausea or fatigue. Treatment is individualised to the patients and comprises routine examinations, laboratory testing, and management of symptoms.
India is one of the most sought-after destinations for Targeted Therapy due to advanced healthcare facilities, well-qualified doctors, and cost-effective treatment. The country has world-class medical technology and internationally accredited hospitals. MediGence ensures a hassle-free experience with personalised assistance from selecting the hospital, travel, and post-treatment care.
MediGence will contact you to arrange an appointment for Targeted Therapy in India. Our case manager will connect you with the top hospitals, schedule consultations with the specialists, and guide you throughout the process, including travel and treatment planning.
The length of stay in India for targeted therapy is determined by the particular treatment plan and the effectiveness with which the patient responds to it. Patients often must stay for four to six weeks to receive the initial treatment and follow-up.
You will be treated with targeted therapy targeting specific cancer cells or areas of your body. It is likely to have fewer side effects and is less aggressive than other treatments. Your doctor will monitor you closely to manage any side effects.
Yes, alternative therapies other than targeted therapy are available in India depending on the condition to be treated. These include immunotherapy, radiation therapy, chemotherapy, and surgery. Doctors may recommend these for patients based on their specific diagnosis, medical history, and response to previous therapies.
MediGence will assist you in preparing for Targeted Therapy in India by providing end-to-end assistance for a hassle-free experience. We connect you with the best hospitals and experienced oncologists for an initial consultation, make necessary diagnostic tests, and provide a treatment plan tailored to your needs.
Our Case Manager will help you coordinate travel, visas, and accommodation and provide personalised support during your stay. MediGence offers the best and safest care in state-of-the-art medical facilities.
